Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bernard Surial
Rates and Predictors of Switching to Tenofovir Alafenamide-Containing ART in a Nationwide Cohort
BMC Infectious Diseases
Infectious Diseases
Calvarial Osteomyelitis in Secondary Syphilis: Evaluation by MRI and CT, Including Cinematic Rendering
Heliyon
Multidisciplinary
Related publications
A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide
Journal of the International Association of Providers of AIDS Care
Dermatology
Infectious Diseases
Immunology
In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir With Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Predictors of Physical Activity Among Older Adults in Germany: A Nationwide Cohort Study
BMJ Open
Medicine
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Rates and Predictors of ACE Inhibitor Discontinuation Subsequent to Elevated Serum Creatinine: A Retrospective Cohort Study
BMJ Open
Medicine
Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection: Rationale and Clinical Trial Evidence
Therapeutic Advances in Gastroenterology
Gastroenterology
Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
